Caroline M. Hamm
London, ON N6A5W9, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Toxicities of CAR-T, Bispecific Antibodies, and Antibody-Drug Conjugates in Multiple Myeloma: A Practical Approach to Risk Mitigation and Management.
Journal: Cancers
Published: May 21, 2026
Connecting Patients with Clinical Trials Using Patient Navigation: A Scoping Review.
Journal: Current oncology (Toronto, Ont.)
Published: April 12, 2026
Redefining 'normal': A Canadian case study of cancer survivors' experiences remaining and/or returning to work during the COVID-19 pandemic.
Journal: PloS one
Published: August 19, 2025
Implementing a national clinical trial navigator program: a qualitative CFIR analysis of barriers and facilitators from the perspective of people with lived cancer experience.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: July 13, 2025
Patient perspective of Hesitancies and strategies to increase cancer clinical trial participation.
Journal: Journal of clinical and translational science
Published: July 03, 2025
A Cohort Study Analysing the Impact of the COVID-19 Pandemic on Colorectal Cancer Presentations in a Medium-Large Canadian Community Hospital.
Journal: Cancer control : journal of the Moffitt Cancer Center
Published: July 02, 2025
Pilot study: A prospective, real-world, feasibility study testing a decreased frequency paradigm in treatment free remission in chronic myeloid leukemia.
Journal: Leukemia research
Published: June 24, 2025
Optimizing Adjuvant Care in Early Breast Cancer: Multidisciplinary Strategies and Innovative Models from Canadian Centers.
Journal: Current oncology (Toronto, Ont.)
Published: May 26, 2025
Connecting patients with clinical trials using patient navigation: a scoping review protocol.
Journal: BMJ open
Published: March 29, 2025
Real-World Experience with CDK4/6 Inhibitors in the First-Line Palliative Setting for HR+/HER2- Advanced Breast Cancer.
Journal: Current oncology (Toronto, Ont.)
Published: November 21, 2024
Adaptive NKG2C+ NK cells in cytomegalovirus seropositive individuals predominantly lack NKR-P1A receptor expression.
Journal: European journal of immunology
Published: October 08, 2024
Last Updated: 09/26/2026